Position in FOLD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$230,751,421
+$146,831,001 QoQ
Shares Held
15,957,913
+170.8% QoQ
Ownership
5.08%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. FOLD ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in FOLD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $230,751,421 | 15,957,913 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $83,920,420 | 5,893,288 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $13,639,136 | 1,730,855 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,702,562 | 1,693,292 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,908,866 | 1,336,871 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,173,891 | 1,080,031 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,023,220 | 563,972 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,828,727 | 486,767 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,577,214 | 897,896 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $11,702,606 | 824,708 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $6,343,507 | 521,670 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $5,031,133 | 400,568 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,997,037 | 270,247 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,037,245 | 576,351 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,916,689 | 183,591 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,010,742 | 280,330 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $4,852,824 | 512,442 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,496,297 | 475,870 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,130,928 | 327,846 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,380,350 | 143,190 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,245,579 | 328,500 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,162,673 | 266,898 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,505,735 | 177,460 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,756,487 | 182,791 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,612,047 | 174,464 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||